Evidence for the gamma‐amino‐butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive‐compulsive disorder
- 31 January 2005
- journal article
- research article
- Published by Wiley in American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics
- Vol. 134B (1) , 25-29
- https://doi.org/10.1002/ajmg.b.30152
Abstract
Obsessive‐compulsive disorder (OCD) is a well‐recognized severe neuropsychiatric illness. Genetic factors are believed to be important etiologically. Although historically genetic testing has focused on the serotonergic and dopaminergic systems, there is increasing evidence that the major inhibitory neurotransmitter, gamma‐aminobutyric acid (GABA), may also be functionally involved. Furthermore the GABA type B receptor 1 (GABBR1) gene has been localized to chromosome 6p21.3 region, which has shown linkage to OCD. We investigated five polymorphisms (A–7265G substitution; C10497G substitution; A33795G substitution in the 3′‐UTR; Ser‐491‐Ser‐T1473C transition; Phe‐659‐Phe‐T1977C transition) in the GABBR1 gene in a sample of 159 DSM‐IV OCD probands and their families, using the transmission disequilibrium test (TDT). A trend was observed with an over‐transmission of −7265A allele at the A‐7265G polymorphism and OCD (χ2 = 3.270, P = 0.071). Moreover, the TDT haplotype analysis using TRANSMIT showed a trend toward association with the haplotype of the five polymorphisms together [2.1.1.2.1 (A‐7265G.C10497G.Ser‐491‐Ser.Phe‐659‐Phe.A33795G)] with a Chi‐square value of 3.418, which corresponds to a P‐value of 0.065 (overall χ2 = 6.353, 5 df, P = 0.273). Moreover, a trend was observed for the total Yale‐Brown obsessive‐compulsive scale score in the A‐7265G polymorphism (−7265A: z = 1.934, P = 0.053) using the Family‐Based Association Test, considering the diagnosis of OCD and then the clinically relevant quantitative phenotypes. The observed trends suggest that further investigations of the role of the GABBR1 gene in OCD are warranted.Keywords
This publication has 27 references indexed in Scilit:
- Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorderMolecular Psychiatry, 2000
- Letters to the EditorThe Canadian Journal of Psychiatry, 2000
- Transmission/Disequilibrium Tests for Extended Marker HaplotypesAmerican Journal of Human Genetics, 1999
- GABAB receptors are involved in the control of acute opiate withdrawal in isolated tissueProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1999
- Phase-IV Multicentre Clinical Study of Risperidone in the Treatment of Outpatients with SchizophreniaThe Canadian Journal of Psychiatry, 1998
- GABAB-activated gK+ in thalamic neurons in the lethargic () mouse model of generalized absence seizuresNeuroscience Letters, 1996
- GABAB receptor antagonists: from synthesis to therapeutic applicationsTrends in Pharmacological Sciences, 1993
- GABAB Receptor PharmacologyAnnual Review of Pharmacology and Toxicology, 1993
- Stimulation of receptors of γ‐aminobutyric acid modulates the release of cholecystokinin‐like immunoreactivity from slices of rat neostriatumBritish Journal of Pharmacology, 1986
- (–)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptorNature, 1980